PAR PHARMACEUTICAL COMPANIES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 3 rows in 2008. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2008-11-18: Reporting owner Campanelli Paul; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-11-18: Reporting owner HAUGHEY THOMAS; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2008-11-18: Reporting owner MacPhee John A; Form 4; Security Common Stock, Option to Buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2008-11-18 | Campanelli Paul Officer (EVP, President-Generics) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +102,881 102,881 owned after | $10.99 exercise price | 2008-11-20 | |
| 2008-11-18 | HAUGHEY THOMAS Officer (EVP, Chief Admin Off, Gen Coun) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +102,881 102,881 owned after | $10.99 exercise price | 2008-11-20 | |
| 2008-11-18 | MacPhee John A Officer (EVP, President, Strativa Pharm) | 4 | Common Stock, Option to Buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +102,881 102,881 owned after | $10.99 exercise price | 2008-11-20 |